
Bausch + Lomb Corporation
Bausch + Lomb Corporation (BLCO) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001860742 · BLCO · NYSE · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001860742 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Bausch + Lomb Corporation (NYSE: BLCO) has submitted 335 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001860742, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Bausch + Lomb Corporation's most comprehensive regulatory disclosure. The most recent Bausch + Lomb Corporation 10-K was filed on 2026-02-18 for fiscal year ending 2026. Historical BLCO 10-K annual reports are available from 2021 through 2026.
Investors researching Bausch + Lomb Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
BLCO SEC Filings · 8 questionsBausch + Lomb Corporation (BLCO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 335 filings and access original documents at no cost. Bausch + Lomb Corporation's CIK is 0001860742.